Article Details
Retrieved on: 2024-08-08 18:39:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Conduit Pharmaceuticals' licensing agreement with AstraZeneca, focusing on the development of therapeutic compounds unrelated to COVID-19. The tags reflect AstraZeneca's broader role in medical research, notably including their work on the COVID-19 vaccine.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here